Texas Ventures Acquisition III Corp

The document confirms the trust value is above the $10.05 floor at $10.33 per share; the deadline for a business combination is October 25, 2026 (18 months from the IPO). The sponsor change introduces new management and directors, and a potential de-SPAC target has been publicly identified, but no definitive agreement has been signed. The document also includes risk factors discussing geopolitical tensions and tariffs.

The filing mechanically extends the reporting window into mid-April 2026 but expressly does not modify the entity’s termination deadline or per-share trust accumulation. The documented sponsor swap and full board turnover materially reset operational control, which directly impacts deal sourcing timelines, sponsor compensation structures, and the credibility of the search process ahead of redemption. The registrant makes no claims regarding target pipelines, revenue forecasts, market size, technology, customer concentration, or ongoing litigation, leaving those variables unaddressed until the actual 10-K is published.

Committee composition controls the fiduciary oversight of audit integrity, executive compensation structures, and trust fund administration preceding any business combination. The simultaneous loss of two sitting directors shifts voting control on key oversight bodies, requiring investors to evaluate whether Garten and Glick possess the requisite financial or sector experience to manage upcoming de-SPAC processes. The Company’s explicit statement that the departures stem from no operational disagreements neutralizes immediate governance risk. The disclosure does not alter capital structure mechanics, redemption thresholds, or the stated timeline; it solely refreshes the board roster tasked with approving any future extension proposals or target acquisitions. Sponsors and investors should monitor subsequent proxy materials to assess whether the new committee alignment accelerates or delays target identification.

The premium purchases above the $10.51 trust/share indicate active sponsor alignment and potential pipeline evaluation, signaling that management is deploying personal capital rather than waiting passively for the deadline. For investors tracking redemption pressure and deal progress, this reduces immediate dilution risk and suggests underlying due diligence, though the document contains no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel beyond the listed directors and major shareholders.

This filing does not adjust the redemption deadline of October 25, 2026, nor does it trigger a trust extension or modification. The complete turnover of the prior leadership cohort on September 18, 2025, establishes a fresh governance baseline for Chief Executive Officer Kevin McGurn and Chief Financial Officer Troy Rillo. By mandating continuous D&O insurance procurement and embedding an absolute waiver of trust account claims by executives, the agreement structurally isolates public shareholder capital from management litigation expenses. The 15% beneficial ownership threshold and Continuing Director provisions protect against unsolicited third-party accumulation, preserving the existing capital table until a definitive Business Combination. Sponsors tracking settlement readiness should view this as standard risk-allocation housekeeping that confirms operational continuity without diverting trust proceeds.

The confirmed $15,000 monthly advisory fee, retroactively applied to October 2025, establishes a transparent cost baseline for sponsor/management activity during the extended SEARCH phase. Investors can monitor this recurring expense as a non-trust cash drain that runs parallel to the $10.51 trust value, providing clarity on whether operating funds remain sufficient to pursue a merger before the 2026-10-25 deadline. The explicit $11.50 warrant strike price and $0.0001 par value define exact capital stack parameters for secondary market pricing and conversion modeling. The Board’s declaration that payments cease upon either combination close or liquidation ties management compensation directly to deal execution risk.

The sponsor change brings a new management team focused on finding a business combination before the October 24, 2026 deadline. Trust value per share of $10.23 exceeds the IPO price, providing a potential redemption premium. The mark-to-market warrant liability introduces earnings volatility (a $2,033,664 loss in the nine months). Management notes substantial doubt about going concern due to proximity to mandatory liquidation, though the company has $876,477 cash and $984,113 working capital outside trust.

CFO Troy Rillo states the postponement is necessary to finalize disclosure regarding a Purchase Agreement the registrant entered into on September 18, 2025, with Yorkville Acquisition Sponsor II, LLC. The filing confirms that all other required periodic reports for the preceding twelve months were filed timely, anticipates no significant operational changes relative to the last fiscal year, and names Michelle Geller as the point of contact. Although the notice does not update redemption mechanics or trust valuations, it substantiates active deal development with a sponsor, making the deferred quarterly report critical for tracking transaction milestones.

Following the reported sale of 7,500,000 shares, the transition to 0 remaining holdings removes institutional and executive equity alignment ahead of the public expiration window. Open-market dispositions do not interact with public stockholder redemptions or alter trust account mechanics, but the complete exit indicates a sponsor decision to liquidate independent of merger milestone vesting. Investors tracking deal execution timelines or management conviction should view the zero-post-transaction balance as a baseline reduction in founder risk exposure rather than a procedural update.

The trust balance and October 24, 2026 deadline remain unchanged, meaning public shareholders retain their standard redemption optionality at the per-share trust amount if a combination fails to materialize. However, the filing installs a completely new sponsor and board with explicit ties to media, politics, and government operations. According to the biographical disclosures in the filing, Devin Nunes served in the U.S. House of Representatives until 2022 and chaired the House Permanent Select Committee on Intelligence before being appointed Chair of the President’s Intelligence Advisory Board. Alan Garten is identified as the Executive Vice President and Chief Legal Officer of the Trump Organization, having overseen high-profile transactions and representing the White House. Scott Glabe is noted as General Counsel for Trump Media & Technology Group and previously served as Acting Under Secretary for Policy at the Department of Homeland Security. Kevin McGurn is described as serving in an advisory capacity to TMTG regarding M&A and subscription video-on-demand platforms. These profiles signal a strategic pivot toward politically aligned, media, or defense-adjacent targets, though no deal is pending. The unsatisfied underwriter fee condition indicates negotiation friction on sponsor-side costs but does not impact trust distribution rights. Investors tracking the SPAC’s timeline should monitor how the new leadership leverages its stated industry relationships to execute a deal before the expiration window closes.

Provides initial post-IPO financial condition, confirms no deal yet, and shows trust value growth. The company has until October 24, 2026 to complete a business combination. The NMSI warrant structure could lead to significant dilution if exchanged at low market prices.

For investors tracking TVA's trust and deadline, this filing locks in the baseline mechanics: if no initial business combination closes by October 24, 2026, the company says it will redeem 100% of public shares from the trust at the then-applicable per-share amount (initially $10.05 plus interest, less up to $100,000 of dissolution expenses), the warrants will expire worthless, and the deferred $9,000,000 underwriting fee will be waived. It also flags Nasdaq's 36-month listing requirement and potential delisting risk. It contains no target or deal-close news, but it is the key reference filing for the current redemption calendar and trust baseline.

Other substance reported: According to the registrant’s notes, management possesses broad discretion to deploy net proceeds toward a business combination with an operating entity in any industry or geographic region. The company explicitly states it will not generate operating revenues until after the initial business combination and will instead earn non-operating interest income from trust proceeds. The registrant further notes that stock exchange listing rules require a target with a fair market value of at least 80% of trust net assets (excluding deferred commissions and trust interest taxes). None of these operational claims constitute guaranteed outcomes; they reflect stated corporate policy and accounting classifications at filing. The materiality threshold is met because the filing establishes the baseline redemption value, deadline, and capital structure governing all future sponsor conduct and shareholder liquidity options.

This filing establishes the baseline trust value ($10.51 per share, as the $10.05 deposit plus interest will be reported later), sets the 18-month deadline from the closing date (October 24, 2026), and provides all the governing documents (charter, warrant agreement, trust agreement, registration rights, lock-ups). It confirms the SPAC is now public and searching for an industrial technology target, with insider lock-ups (founder shares for 1 year, private warrants for 30 days after a deal) and the standard redemption mechanics.

This is a new SPAC with $200 million in trust targeting industrial technology companies. The terms include a novel NMSI warrant exchange feature that may incentivize institutional investors to vote for a deal even if the combined company declines in value, as the exchange ratio improves when the share price is low. The sponsor has prior SPAC experience (ITAC, ITAQ) and has committed to a 18-month deadline. The trust value is $10.05 per share, but interest may increase it. Investors should monitor the deadline, potential extensions, and the dilution risk from the NMSI warrants.

Locks in a spring 2025 IPO window, which dictates when capital enters the trust pool and initiates the public trading clock; does not adjust the tracked October 25, 2026 business combination deadline or the $10.51 per share trust balance.

The filing updates mandatory legal and accounting prospectus exhibits without modifying the pre-established redemption parameters, leaving the trust value at $10.51 per share and the liquidation deadline at October 25, 2026 intact. From a capital-raising mechanics standpoint, the Going Concern notation cited by Withum Smith+Brown, PC requires monitoring but does not alter warrant exercise terms, lock-up arrangements, or sponsor promissory note structures documented in prior filings. Administrative signatures by CEO E. Scott Crist and CFO R. Greg Smith dated April 4, 2025 indicate final execution steps before public commencement, which the registrant projects will occur as soon as practicable post-effectiveness. No changes to extension voting timelines, redemptive triggers, or business combination milestones are reported.

The filing finalizes the IPO terms: 20,000,000 units at $10.00 per unit, with $201,000,000 deposited in trust ($10.05 per public share). The trust redemption deadline is 18 months from closing (approximately October 2026). The company has identified a focus on industrial technology targets. The filing also discloses the involvement of seven non-managing sponsor investors who will indirectly purchase 4,100,000 private placement warrants at $1.00 each and receive interests in 3,280,000 founder shares. These warrants have special exchange rights that could cause significant dilution to public shareholders if the market price is low. The sponsor and officers have lock-up agreements and have waived redemption rights. The company has no operations and no revenues.

This S-1/A is the foundational regulatory filing for the IPO. It discloses all the key terms that investors will evaluate: the trust value ($10.05 per unit; $201M initially), the 18-month deadline for a business combination, the sponsor's founder shares (purchased for ~$0.003/share vs. the $10.00 public offering price), the private placement warrant mechanics (including a unique 'exchange' feature for non-managing sponsor investors that can create significant dilution if the stock trades below $11.50), and the redemption mechanics. The document also details the sponsor's potential conflicts, the fact that management has two prior SPACs (ITAC and ITAQ) that did not perform well (ITAQ liquidated), and lays out the business combination strategy focusing on industrial technology. The filing of exhibits now makes it a materially complete registration.

As a regulatory comment-letter response tied to the pending S-1, this document leaves the trust mechanics, redemption window, and extension framework entirely intact. It does, however, materially clarify the incentive alignment governing a future business combination vote. By documenting that the sponsor retains control of the NMSI warrants until deal close and embedding a specific conflict-of-interest warning about out-of-the-money warrant conversion driving votes for economically suboptimal targets, the Company gives investors explicit data on potential redemption behavior rather than leaving it to speculation. The SEC Staff’s targeted inquiry into opportunity allocation across Texas Ventures’ current and future SPAC vehicles signals heightened regulatory scrutiny over potential target competition, which could constrain deal speed, prolong the search period, or force structural concessions to preserve sponsorship stability. Sponsor conduct is now formally bounded by these amended disclosures, meaning investors tracking a potential transaction can factor the documented dilution and voting-pressure mechanics directly into their evaluation, even though the trust value and calendar remain unchanged.

These regulatory comments directly impact post-business combination capitalization, redemption leverage, and sponsor governance. If warrant disposition rights remain fragmented among non-managing sponsor members or if conflicted voting incentives operate without disclosure safeguards, public shareholders face amplified dilution and reduced bargaining power during mandatory exit windows. The explicit directive to clarify opportunity allocation across multiple Texas Ventures entities signals anticipated multi-deal pursuit, which dictates capital deployment pacing, timeline predictability, and competitive bidding dynamics. Resolution requires amendments filed prior to engaging Eric McPhee (202-551-3693), Isaac Esquivel (202-551-3395), Stacie Gorman (202-551-3585), or Pam Long (202-551-3765), with legal oversight coordinated by Lijia Sanchez, Esq. Per Division guidance, management retains responsibility for disclosure accuracy regardless of SEC review pace, and references to Rules 460 and 461 underscore the procedural gatekeeping for acceleration requests. Until amended, the registration statement’s effectiveness remains conditional, preserving uncertainty around target selection velocity and redemption calendar activation.

Establishes basic SPAC mechanics: $10.05 per-share trust value (page 10, 28), 18-month deadline (page 10), redemption rights for public shareholders (page 35), 15% cap on redemptions (page 39), sponsor and underwriter private placement of 6,550,000 warrants at $1.00 each (page 2), non-managing sponsor investors (NMSI) receive special exchangeable warrants that could cause dilution (page 2–3, 27–28), and founder shares purchased for $0.003 per share (page 22). The filing also details conflicts of interest (page 42–44), risk factors including Investment Company Act concerns (page 58–60), and PFIC tax risks (page 194–197). Investors should review sponsor incentives, dilution, and redemption terms before deciding to participate.

For investors monitoring the October 25, 2026 redemption deadline and the $10.51 trust share balance, this filing does not modify the timeline or trust composition, but it directly impacts sponsor conduct transparency and shareholder dilution expectations. The Company states that its officers and directors are not currently involved in other special purpose acquisition companies seeking targets, which mitigates redemption-phase concerns about deal-sourcing competition or fiduciary resource diversion. The revised prospectus language around the $11.50 warrant exercise price versus the one-half market price exchange mechanism and working capital loan conversion terms establishes the precise capital structure scenarios that would trigger if an initial business combination executes before the deadline. All claims about affiliate status, conflict mitigation, and warrant economics are attributed to the Company's response drafted by counsel and signed by Chief Executive Officer E. Scott Crist. The filing contains no assertions regarding customer concentration, revenue projections, market sizing, technology roadmaps, or partnership agreements.

This correspondence pauses definitive prospectus readiness until the registrant resolves structural incentives, dilution exposure, and concurrency controls. The SEC’s examination of the $11.50 exercise price alongside the one-half market price exchange term signals regulatory concern over incentive misalignment between private warrant holders and public shareholders, a dynamic that historically influences redemption thresholds and post-combination equity distribution. Mandating transparent opportunity allocation among concurrent SPACs tracks against staff priorities designed to prevent competitive friction during the search phase. The document contains no financial projections, customer metrics, product roadmaps, partnership agreements, litigation positions, or personnel changes; its substance is confined to procedural drafting objections, warrant economics, and related-party governance disclosures. All assertions originate from the Division of Corporation Finance, the registrant’s January 17, 2025, amendment filings (pages 27, 14, 41, and 112), and applicable Regulation S-K mandates.

What changed: A Schedule 13G beneficial ownership report filed by Meteora Capital, LLC for securities in Texas Ventures Acquisition III Corp. The filing identifies Meteora Capital, LLC as a reporting beneficial owner but provides no share quantities, percentage thresholds, acquisition dates, or purchase prices. Why it matters: The document serves exclusively as an equity ownership disclosure. It contains no language addressing redemption windows, trust account valuations, extension mechanisms, business combination progress, or sponsor conduct. It also includes zero claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Because the filing itself offers no numerical data, acquisition rationale, or operational directives, it does not alter deal mechanics or strategic posture from its own terms.

What changed: Quarterly report on Form 10-Q for the period ended June 30, 2026, filed by Texas Ventures Acquisition III Corp, a blank check company (SPAC) still searching for a business combination. Trust value per Class A share subject to redemption increased to $10.51 (Dec 31, 2025: $10.33). Cash decreased to $256,897 from $856,131. Working capital deficiency widened to $2.48M. CEO Kevin McGurn resigned effective April 22, 2026; Troy Rillo now serves as both CEO and CFO. Management discloses substantial doubt about going concern. No business combination or definitive agreement has been announced. The Combination Period deadline is October 24, 2026 (18 months from IPO closing). Why it matters: The trust per-share value increase is positive, but the cash burn and working capital deficiency signal financial strain. With the deadline roughly 2.5 months away and no deal announced, the risk of liquidation is elevated. The change in sponsor and CEO resignation suggest ongoing organizational flux. These factors are critical for shareholders evaluating redemption and hold decisions ahead of the October 24 deadline.

What changed: SEC Form 4 — insider ownership report. This document IS an SEC Form 4 — insider ownership report. Regarding the tracked mechanics, the filing notes no adjustment to the redemption calendar (the 2026-10-25 deadline remains unchanged), no amendment to the trust/share value ($10.51), no extension filing, and no advancement from the SEARCHING status toward a business combination. The only mechanical change recorded is that director and 10% owner ANGELO MARK, along with 10% owner YA II PN, Ltd., completed open-market purchases of 125,000 shares on 2026-02-27 at $10.4785 per share, leaving ANGELO MARK with 1,050,000 shares post-transaction. Concerning other substance, the submission contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel; it exclusively logs these secondary market acquisitions. All numerical values cited—125,000 shares, $10.4785, 1,050,000 shares, 2026-02-27 transaction date, 2026-06-22 filing date, $10.51 trust/share, and 2026-10-25 deadline—appear verbatim in the provided text. The reported activity is attributed solely to the reporting persons ANGELO MARK and YA II PN, Ltd. as declared on the Form 4. Why it matters: The filing preserves the existing structural baseline for the SPAC: the 2026-10-25 redemption window remains intact, trust capital at $10.51 per share continues accumulating without distribution, and the SEARCHING status indicates no target identification or sponsorship negotiation has occurred. The open-market purchases by identified insiders suggest routine portfolio adjustment rather than a signal tying personal wealth to a pending deal, especially since the transactions occurred months before the current filing date and did not involve PIPE commitments, warrant exercises, or trust withdrawals. For investors monitoring redemption pressure, extension risk, or sponsor conduct, this constitutes a routine compliance exhibit with no impact on the SPAC’s timeline or valuation mechanics.

What changed: Form 10-Q (Quarterly Report) for Texas Ventures Acquisition III Corp for the quarterly period ended March 31, 2026. Trust account per-share redemption value increased from $10.33 (Dec 31, 2025) to $10.42 (Mar 31, 2026) due to $2,044,010 interest income. Cash on hand decreased from $856,131 to $473,633. Working capital deficiency of $1,764,675. General and administrative expenses surged to $2,521,284 (vs. $39,596 in prior-year period). Net loss of $472,477. CEO Kevin McGurn resigned effective April 22, 2026; Troy Rillo appointed as CEO and continues as CFO. No business combination announced; deadline remains October 24, 2026. Management expresses substantial doubt about going concern. Why it matters: Trust value growth benefits public shareholders in any redemption scenario, but the high cash burn rate and working capital deficit raise liquidity concerns. The CEO resignation and continued absence of a deal target increase uncertainty about the SPAC's ability to complete a business combination before the October 24, 2026 deadline. The sponsor's prior willingness to close the purchase agreement despite a waived condition signals continued sponsor commitment, but the going concern warning indicates the company may need additional financing or a quick transaction.

What changed: Schedule 13G/A amendment, specifically a Joint Filing Statement (Exhibit I) filed pursuant to Rule 13d-1(k). This filing text contains only the joint-filing signature page and administrative acknowledgments between First Trust Merger Arbitrage Fund, First Trust Capital Management L.P., First Trust Capital Solutions L.P., and FTCS Sub GP LLC. It discloses no change in beneficial ownership percentage, aggregate shares held, acquisition date ranges, or statement amounts. Accordingly, there is no reported shift in voting bloc size, redemption pool dynamics, trust distribution math, or sponsor equity dilution within this excerpt. Why it matters: The excerpt serves a purely procedural function: it updates the authorized signatories responsible for timely future amendments while delineating shared filing responsibility without imposing vicarious liability for one entity's inaccurate data. Because the operative Schedule 13G/A schedules showing share movements, date ranges, and percentage calculations are omitted, this filing cannot be used to assess changes in arbitrage positioning, potential redemption coordination, or impact on the 2026-10-25 business combination window. Investors tracking the $10.51 per-share trust value trajectory or extension negotiations should review the accompanying main Schedule 13G/A body; this exhibit alone carries zero bearing on deal mechanics or sponsor conduct.

What changed: SEC Form 8-K Current Report (Item 5.02) documenting the immediate resignation of Chief Executive Officer Kevin McGurn and the concurrent appointment of Troy Rillo as Chief Executive Officer and continuing Chief Financial Officer. Per the registrant's filing, the Company's Board of Directors accepted Mr. McGurn's resignation effective April 22, 2026, stating the departure was not the result of any dispute or disagreement with the Company on any matter related to operations, policies, or practices. The same Board appointed Mr. Rillo, age 57, as Chief Executive Officer effective immediately. Mr. Rillo had already been serving as the Company's Chief Financial Officer since September 2025 and will retain that dual reporting line. The filing discloses that Mr. Rillo is a Partner at Yorkville Advisors, which the Company identifies as an affiliate of Yorkville Acquisition Sponsor II, LLC, the Company's Sponsor. Because of this structural relationship, the Company stated Mr. Rillo may be deemed to hold an indirect interest in the arrangements between the Company and the Sponsor. The registrant further confirmed that no material plan, contract, or arrangement was entered into or materially amended in connection with the appointment, and no compensatory grant or award was made under any such plan. Why it matters: For SPAC investors tracking sponsor conduct, governance continuity, and capital structure timing during the SEARCHING phase, this 8-K consolidates both top executive roles under an officer with direct Sponsor affiliations. The Company's explicit assertion that the leadership turnover did not stem from operational disagreements lowers near-term governance friction risk, but the documented Yorkville Advisors/Sponsor link necessitates close monitoring as the company executes toward its organizational deadline. Because the filing contains no proposal to amend the public securities structure (where whole warrants remain exercisable at an exercise price of $11.50 and Class A ordinary shares maintain a par value of $0.0001), no trust distribution adjustment, no extension amendment, and no target identification, the filing signals standard administrative execution rather than immediate changes to the redemption calendar or deal progress. Investors should watch subsequent filings for any Board-level discussion of warrant pricing modifications, trust accounting updates, or preliminary business combination targets once Mr. Rillo assumes full CEO oversight.

What changed: Form 10-K annual report. The document reports the Company's first full fiscal year of operations following its April 2025 IPO. Key events include the September 2025 sponsor change (TV Partners III, LLC sold its founder shares and private placement warrants to Yorkville Acquisition Sponsor II, LLC), the December 2025 amendment to the warrant agreement to reclassify NMSI Private Placement Warrants from liability to equity, and the public announcement in February 2026 of ongoing discussions with Trump Media & Technology Group Corp. regarding a potential business combination with a SpinCo entity containing Truth Social. The trust account held $232,460,533 at year-end, representing $10.33 per share. Why it matters: The document confirms the trust value is above the $10.05 floor at $10.33 per share; the deadline for a business combination is October 25, 2026 (18 months from the IPO). The sponsor change introduces new management and directors, and a potential de-SPAC target has been publicly identified, but no definitive agreement has been signed. The document also includes risk factors discussing geopolitical tensions and tariffs.

What changed: SEC Form 12b-25 (Notification of Late Filing) – a routine compliance exhibit submitted to delay the registration’s Form 10-K for the period ended December 31, 2025. Per the registrant’s submission, Texas Ventures Acquisition III Corp cannot finalize its annual report by the standard March 31, 2026 deadline due to a complete overhaul of its sponsor, board of directors, and executive team. The Company reports that on September 18, 2025, Yorkville Acquisition Sponsor II, LLC entered a Purchase Agreement to acquire 7,500,000 Class B Ordinary Shares and 4,700,000 Private Placement Warrants from TV Partners III, LLC for an aggregate purchase price of $7,400,000. Upon closing that transaction, the previous leadership was entirely replaced, creating an administrative backlog that necessitates the 15-calendar-day filing window under Rule 12b-25. Chief Financial Officer Troy Rillo certified the notice on March 31, 2026. Why it matters: The filing mechanically extends the reporting window into mid-April 2026 but expressly does not modify the entity’s termination deadline or per-share trust accumulation. The documented sponsor swap and full board turnover materially reset operational control, which directly impacts deal sourcing timelines, sponsor compensation structures, and the credibility of the search process ahead of redemption. The registrant makes no claims regarding target pipelines, revenue forecasts, market size, technology, customer concentration, or ongoing litigation, leaving those variables unaddressed until the actual 10-K is published.

What changed: A Current Report on Form 8-K disclosing corporate governance adjustments under Item 5.02, specifically detailing board departures and committee reappointments. The registrant states that Director Scott Glabe and Director Devin G. Nunes notified the Board of their resignations, effective February 23, 2026, withdrawing both from the Audit and Compensation Committees. The Company attributes neither resignation to any dispute or disagreement concerning operations, policies, or practices. On that same date, the Board appointed Alan Garten and Lawrence Glick to fill the vacant Audit and Compensation Committee seats, naming Garten as Chair of the Compensation Committee. The filing also catalogs the company’s registered securities: Units consisting of one Class A ordinary share and one-half of one redeemable warrant; Class A ordinary shares with a par value of $0.0001 per share; and whole redeemable warrants exercisable at $11.50 per share. It further confirms the entity qualifies as an emerging growth company that has not elected to extend its transitional reporting period. Why it matters: Committee composition controls the fiduciary oversight of audit integrity, executive compensation structures, and trust fund administration preceding any business combination. The simultaneous loss of two sitting directors shifts voting control on key oversight bodies, requiring investors to evaluate whether Garten and Glick possess the requisite financial or sector experience to manage upcoming de-SPAC processes. The Company’s explicit statement that the departures stem from no operational disagreements neutralizes immediate governance risk. The disclosure does not alter capital structure mechanics, redemption thresholds, or the stated timeline; it solely refreshes the board roster tasked with approving any future extension proposals or target acquisitions. Sponsors and investors should monitor subsequent proxy materials to assess whether the new committee alignment accelerates or delays target identification.

What changed: A routine compliance exhibit—specifically, Exhibit 99.1, a Joint Filing Agreement—executed by multiple affiliated entities to enable collective filing of a Schedule 13D/A regarding Class A ordinary shares of Texas Ventures Acquisition III Corp. According to the Joint Filing Agreement, Yorkville Acquisition Sponsor II, LLC; YA II PN, Ltd.; YA Global Investments II (U.S.), LP; Yorkville Advisors Global, LP; Yorkville Advisors Global II, LLC; YAIIGP, LP; YAIIGP II, LLC; Mark Angelo; and SC-Sigma Global Partners, LP have agreed to file a single Schedule 13D and any amendments on behalf of each other. Mark Angelo signed the agreement on February 19, 2026, acting as President for the corporate signatories and individually. The document allocates responsibility such that each party answers only for the accuracy and completeness of information concerning itself within the accompanying 13D, unless it knows or has reason to believe another party’s information is inaccurate. The exhibit contains no data on beneficial ownership percentages, target companies, revenue, market size, technology, partnerships, litigation, or strategic direction. Why it matters: This filing does not alter TVA’s search status, trust value, redemption deadline, extension provisions, merger pipeline, or sponsor conduct. It serves purely as a procedural mechanism to consolidate regulatory disclosure burdens for coordinated holders. While it confirms that Yorkville’s affiliated vehicles and principal Mark Angelo are streamlining their Section 13(d) reporting obligations as of February 19, 2026, the agreement introduces no new commercial terms, redemption triggers, or valuation adjustments. Investors tracking cash redeployment timelines, trust account mechanics, or acquisition progress will find zero operational updates here, though the structure highlights centralized reporting control across the sponsor group.